iTalk Inc. - FORM 10-Q - XML - IDEA: XBRL DOCUMENT - April 16, 2012



Attached files
FileFilename
XML - IDEA: XBRL DOCUMENT - iTalk Inc.R5.htm
XML - IDEA: XBRL DOCUMENT - iTalk Inc.R4.htm
XML - IDEA: XBRL DOCUMENT - iTalk Inc.R1.htm
XML - IDEA: XBRL DOCUMENT - iTalk Inc.R7.htm
XML - IDEA: XBRL DOCUMENT - iTalk Inc.R6.htm
XML - IDEA: XBRL DOCUMENT - iTalk Inc.R2.htm
XML - IDEA: XBRL DOCUMENT - iTalk Inc.R8.htm
EXCEL - IDEA: XBRL DOCUMENT - iTalk Inc.Financial_Report.xls
EX-32.2 - iTalk Inc.ex32-2.txt
EX-32.1 - iTalk Inc.ex32-1.txt
EX-31.2 - iTalk Inc.ex31-2.txt
EX-31.1 - iTalk Inc.ex31-1.txt
10-Q - iTalk Inc.g5880.txt
People who read this document also read:
Document
CHEMBIO DIAGNOSTICS, INC. - 8-K, Regulation FD Disclosure Financial Statements and Exhibits
STRUCTURED PRODUCTS CORPTIERS PRINC PROT CERTS TR SER PXT - 8-K, Other Events Financial Statements and Exhibits
v2.4.0.6
SOPAC CELLULAR SOLUTIONS INC.- (A Development Stage Company) - Statement of Operations (USD $)
3 Months Ended 6 Months Ended 68 Months Ended
Feb. 29, 2012
Feb. 28, 2011
Feb. 29, 2012
Feb. 28, 2011
Feb. 29, 2012
Total Revenues $ 0 $ 0 $ 0 $ 0 $ 0
Professional Fees 1,500 1,500 5,000 5,000 42,250
General and Administrative Expenses 905 508 1,770 1,446 23,221
General and Administrative Expenses - Related Party 300 300 600 600 6,200
Total Operating Expenses 2,705 2,308 7,370 7,046 71,671
Provision for Income Taxes 0 0 0 0 0
Net Income (Loss) $ (2,705) $ (2,308) $ (7,370) $ (7,046) $ (71,671)
Basic earnings (loss) per share $ 0 $ 0 $ 0 $ 0 $ 0
Weighted average number of common shares outstanding 1,700,000 1,700,000 1,700,000 1,700,000  

User Contributions:

Comment about this document or add new information about this topic:

CAPTCHA



This web site and associated pages are not associated with, endorsed by, or sponsored by iTalk Inc. and has no official or unofficial affiliation with iTalk Inc.


Based on public records. Inadvertent errors are possible.
Faqs.org does not guarantee the accuracy or timeliness of any information on this site.  Use at your own risk. This website is not associated with the SEC

Some parts © 2013 Advameg, Inc.